Islet cell damage associated with tacrolimus and cyclosporine: Morphological features in pancreas allograft biopsies and clinical correlation

Transplantation

Volumn 68, Issue 3, 1999, Pages 396-402

  Drachenberg, Cinthia B ^a   Klassen, David K ^a   Weir, Matthew R ^a   Wiland, Ann ^a   Fink, Jeffrey C ^a   Bartlett, Stephen T ^a   Cangro, Charles B ^a   Blahut, Steven ^a   Papadimitriou, John C ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; GLUCAGON; INSULIN; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; ELECTRON MICROSCOPY; FEMALE; GLUCOSE METABOLISM; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; PANCREAS BIOPSY; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

ADULT; BIOPSY; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; HYPERPLASIA; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; PANCREAS TRANSPLANTATION; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VACUOLES;

EID: 0033567135     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199908150-00012     Document Type: Article

References (55)

1. Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, Strom TB. Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med 1984; 101: 667.
2. Brayman KL, Egidi FM, Naji A, et al. Renal transplantation at the University of Pennsylvania Medical Center: an update of results in the cyclosporine era. Clin Transplant 1992; 215.
3. Anonymous. Randomized trial comparing FK506 (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet 1994; 1: 423.
4. Gruessner RW, Burke GW, Stratta R, et al. A multi-center analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Transplantation 1996; 61: 261.
5. Ghoneim MA, Sobh MA, Shokeir AA, Bakr MA, el-Sherif AK, Fouda MA. Prospective randomized study of azathioprine versus cyclosporin in live-donor kidney transplantation. Am J Nephrol 1993; 13: 437.
6. Mayer AD, Dmitrewski J, Squifflet JP, et al. Multicenter randomized trial comparing FK506 (FK506) and cyclosporin in the prevention of renal allograft rejection: a report of the European FK506 Multicenter Renal Study Group. Transplantation 1997; 64: 436.
7. Boudreaux JP, McHugh L, Canafax DM, et al. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 1987; 44: 376.
8. Sumrani NB, Delaney V, Ding ZK, et al. Diabetes mellitus after renal transplantation in the cyclosporine era - an analysis of risk factors Transplantation 1991; 51: 343.
9. Schneider DJ, Nordt TK, Sobel BE. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes 1993; 42: 1.
10. Miles Am, Sumrani N, Horowitz R et al. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation 1998; 65: 380.
11. Arner P, Gunnarsson R, Blomdahl S, Groth CG. Some characteristics of steroid diabetes: a study in renal transplant recipients receiving high dose corticosteroid therapy. Diabetes Care 1983; 6: 23.
12. Munck A. Glucocorticoid inhibition of glucose uptake by peripheral tissues: old and new evidence, molecular mechanisms, and physiological significance. Perspect Biol Med 1971; 14: 265.
13. Kahn CR, Goldfine ID, Neville DM, DeMeyts P. Alteration in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone. Endocrinology 1978; 103: 1054.
14. Venkatesan N, Davidson MB, Hutchinson A. Possible role for the glucose-fatty acid cycle in dexamethasone-induced insulin antagonism in rats. Metabolism 1987; 36: 883.
15. Madar I, Mihail N. Age-related effect of treatment by hydrocortisone upon the histological structure of endocrine pancreas and on the blood glucose in normal and diabetic young rats. Endocrinologie 1983; 21: 37.
16. Bhatt SD, Khanna SS. Histopathology of the endocrine pancreas of a fresh-water fish, Clarias Batrachus L.VII. Effects of hydrocortisone and thyroxine administration. Acta Biol Acad Sci Hung 1976; 27: 25.
17. Tomita T, Visser P, Friesen S, Doull V. Cortisone-induced islet cell hyperplasia in hamsters. Virchows Arch B Cell Pathol Incl Mol Pathol 1984; 45: 85.
18. Rao M, Jacob CK, Shastry JC. Post-renal transplant diabetes mellitus - a retrospective study. Nephrol Dial Transplant 1992; 7: 1039.
19. Hricik DE, Bartucci MR, Moir EJ, Mayes JT, Schulak JA. Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplantation 1991; 51: 374.
20. von Kiparski A, Frei D, Uhlschmid G, Largiader F, Binswanger U. Post-transplant diabetes mellitus in renal allograft recipients: a matched-pair control study. Nephrol Dial Transplant 1990; 5: 220.
21. Bartlett ST, Schweitzer EJ, Johnson LB, et al. Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tracrolimus immunosuppression with percutaneous biopsy. Ann Surg 1996; 224: 440.
22. Yale JF, Roy RD, Seemayer TA, Murphy GF, Marliss EB. Effects of cyclosporine: Glucose tolerance in the rat. Diabetes 1985; 34: 1309.
23. Hirano Y, Fujihira S, Ohara K, Katsuki S, Noguchi H. Morphological and functional changes of islets of Langerhans in FK506-treated rats. Transplantation 1992; 53: 889.
24. Tze WJ, Tai J, Murase N, Tzakis A, Starzl TE. Effect of FK506 on glucose metabolism and insulin in normal rats. Transplant Proc 1991; 23: 3158.
25. Rilo HL, Zeng Y, Alejandro R, et al. Effect of FK506 on function of human islets of Langerhans. Transplant Proc 1991; 23: 3164.
26. Strasser S, Alejandro R, Shapiro ET, Ricordi C, Todo S, Mintz DH. Effect of FK506 on insulin secretion in normal dogs. Metabolism 1992; 41: 64.
27. Stratta RJ, Taylor RJ, Bynon JS, et al. Surgical treatment of diabetes mellitus with pancreas transplantation. Ann Surg 1994; 220: 809.
28. Drachenberg CB, Papadimitriou JC, Klassen DK, et al. Evaluation of pancreas transplant needle biopsy: reproducibility and revision of histologic grading system. Transplantation 1997; 63: 1579.
29. Drachenberg CB, Ioffe OB, Papadimitriou JC. Progressive increase in apoptosis in prostatic intraepithelial neoplasia and prostatic carcinoma: comparison between in situ en-labeling of DNA fragments and detection by routine H&E staining. Arch Pathol Lab Med 1997; 121: 54.
30. Papadimitriou JC, Drachenberg CB. Ultrastructural analysis of asteroid bodies: Evidence for membrane lipid bilayer nature of components. Ultrastruct Pathol 1992; 16: 413.
31. Friedman EA, Shyh TP, Beyer MM, Manis T, Butt KM. Post-transplant diabetes in kidney transplant recipients. Am J Nephrol 1985; 5: 196.
32. Shapiro R, Jordan ML, Scantlebury VP, et al. A prospective, randomized trial of FK506/prednisone vs FK506/azathioprine/ prednisone in renal transplant patients. Transplant Proc 1995; 27: 814.
33. Krentz AJ, Dousset B, Mayer D, et al. Metabolic effects of cyclosporine A and FK506 in liver transplant recipients. Diabetes 1993; 42: 1753.
34. Yoshimura N, Nakai I, Ohmori Y, et al. Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients. Am J Kidney Dis 1988; 12: 11.
35. Morris PJ. Cyclosporin, FK506 and other drugs in organ transplantation. Curr Opin Immunol 1991; 3: 748.
36. Cantarovich D, Dantal J, Murat A, Soulillou JP. Normal glucose metabolism and insulin secretion in CyA-treated nondiabetic renal allograft patients not receiving steroids. Transplant Proc 1990; 22: 643.
37. Cantarovich D, Murat A, Hourmant M, Bardet S, Soulillou JP. Is cyclosporin toxic for human pancreas? Transplant Proc 1988; 20: 449.
38. Ost L. Impairment of prednisolone metabolism by cyclosporine treatment in renal graft recipients. Transplantation 1987; 44: 533.
39. Hahn HJ, Laube F, Lucke S, Kloting I, Kohnert KD, Warzock R. Toxic effects of cyclosporine on the endocrine pancreas of Wistar rats. Transplantation 1986; 41: 44.
40. Eun HM, Pak CY, Kim CJ, McArthur RG, Yoon JW. Role of cyclosporine A in macromolecular synthesis of beta-cells. Diabetes 1987; 36: 952.
41. Stockmann F, Fehmann HC, Goke B, Siegel EG, Creutzfeldt W. Impairment of stimulated insulin release from the isolated perfused rat pancreas by cyclosporine treatment. Transplantation 1989; 48: 381.
42. Wahlstrom HE, Akimoto R, Endres D, Kolterman O, Moossa AR. Recovery and hypersecretion of insulin and reversal of insulin resistance after withdrawal of short-term cyclosporine treatment. Transplantation 1992; 53: 1190.
43. Andersson A, Borg M, Hallberg A, Hellerstrom C, Sandler S, Schnell A. Long term effects of cyclosporine A on cultured mouse pancreatic islets. Diabetologia 1984; 17: 66.
44. Nielsen JH, Mandrup-Poulsen T, Nerup J. Direct effects of cyclosporine A on human pancreatic beta-cells. Diabetes 1986; 35: 1049.
45. Gillison SL, Bartlett ST, Curry DL. Inhibition by cyclosporine of insulin secretion - a beta cell-specific alteration of islet tissue function. Transplantation 1991; 52: 890.
46. Shapiro R, Jordan ML, Scantlebury VP. FK506 in clinical kidney transplantation. Transplant Proc 1991; 23: 3065.
47. Scantlebury V. Shapiro R, Fung J, et al. New onset of diabetes in FkK506 vs Cyclosporine-treated kidney transplant recipients. Transplant Proc 1991; 23: 3169.
48. Tamura K, Fujimura T, Tsutsumi T, et al. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation 1995; 59: 1606.
49. Ricordi C, Zeng YJ, Alejandro R, et al. In vivo effect of FK506 on human pancreatic islets. Transplantation 1991; 52: 519.
50. Tabasco-Minguillan J, Mieles L, Carroll P, Gavaler J, Van Thiel DH, Starzl TE. Insulin requirements after liver transplantation and FK506 immuno suppression. Transplantation 1993; 56: 862.
51. Christiansen E, Tibell A, Volund AA, et al. Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance. J Clin Endocrinol Metab 1997; 82: 2299.
52. Gruessner RW. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Study Group. Clin Transplant 1997; 11: 299.
53. Ensley RD, Bristow MR, Olsen SL, et al. The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients. Transplantation 1993; 56: 75.
54. Fabian MC, Lakey JR, Rajotte RV, Kneteman NM. The efficacy and toxicity of rapamycin in murine islet transplantation. In vitro and in vivo studies 1993; 56: 1137.
55. Papadimitriou J, Drachenberg CB, Wiland A, et al. Histologic grading of acute allograft rejection in pancreas needle biopsies: Correlation to serum enzymes, glycemia and response to immunosuppressive treatment. Transplantation (in press).